CANCER TREATMENT USING ANTI-NKG2A AGENTS
- 专利权人:
- 发明人:
- 申请号：
- RU2017107559
- 公开号：
- RU2017107559A3
- 申请日:
- 申请国别(地区):
- RU
- 年份:
- 2019
- 代理人:
- 摘要：
- The present disclosure relates to HLA-E as a tumor escape mechanism in head and neck cancer. The disclosure relates to methods for the treatment of head and neck cancer, notably HLA-E expressing head and neck squamous cell carcinoma, using antibodies that specifically bind and inhibit human NKG2A.
- 来源网站：
- 中国工程科技知识中心
